Demographics (1)
- SEX - Biological sex (phv00487771.v1.p1)
Disease Events (2)
- AFFECTION_STATUS - Case control status of the subject for prostate cancer (phv00487775.v1.p1)
- METASTASIS - Patient has metastatic prostate cancer (phv00487777.v1.p1)
General Health (1)
- SURGERY - Patient underwent surgical removal of prostate (phv00487776.v1.p1)
Other (17)
- ANALYTE_TYPE - Analyte Type (phv00487782.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00487781.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00487770.v1.p1)
- IMMUNOGENIC - Patient has immunogenic prostate cancer (phv00487779.v1.p1)
- IS_BASELINE - Baseline status (phv00487785.v1.p1)
- IS_METASTASIS - Metastasis status (phv00487788.v1.p1)
- IS_POST-TREATMENT - Post-treatment status (phv00487786.v1.p1)
- IS_TUMOR - Tumor status (phv00487783.v1.p1)
- IS_XENOGRAFT - Xenograft status (phv00487787.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00487784.v1.p1)
- SAMPLE_ID - Sample ID (phv00487780.v1.p1)
- SAMPLE_ID - Sample ID (phv00487773.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00487789.v1.p1)
- SUBJECT_ID - Subject ID (phv00487774.v1.p1)
- SUBJECT_ID - Subject ID (phv00487769.v1.p1)
- SUBJECT_ID - Subject ID (phv00487772.v1.p1)
- SURVEILLANCE - Patient remained on active surveillance protocol (phv00487778.v1.p1)